High-intensity vs. Low-intensity Inspiratory Muscle Training in Patients With Heart Failure
NCT ID: NCT03247361
Last Updated: 2018-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2017-08-01
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training in Hospitalized Heart Failure Patients
NCT07108231
Inspiratory Muscle Training Effectiveness in Sympathetic Activity and Functional Capacity in Patients With Heart Failure
NCT02600000
Exercise Training Associated With Inspiratory Muscle Training in Heart Failure
NCT01747395
Inspiratory Muscle and Peripheral Muscle Training in Chronic Heart Failure
NCT02263482
Inspiratory Muscular Training
NCT01593007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High-intensity IMT
High-intensity IMT + Aerobic/resistance exercise
IMT: Training loads will be adjusted weekly to the maximal inspiratory pressure (MIP). In the first 2 weeks as adaptation, the protocol will be of 2 minutes warm-up with intensity 20% of MIP. The training will have 7 peaks of intensity with 70% of MIP for 30 sec, with 30-sec of passive rest between the peaks, finishing the training with 20% of MIP for 2 min, totaling 10 min and 30 sec. From the third week the protocol will be of 2 min warm-up with intensity 30% of MIP. The training will have 7 peaks of intensity with 70% of MIP for 60 sec, with 60-second of passive rest between the peaks, finishing the training with 20% of MIP for 2 min, totaling 17 min.
Exercise: see group Combined aerobic/resistance exercise
High-intensity IMT + Aerobic/resistance exercise
High-intensity IMT
Low-intensity IMT
Low-intensity IMT + Aerobic/resistance exercise
IMT:Training loads will be also adjusted weekly to the maximal inspiratory pressure (MIP). In the first two weeks as adaptation, the protocol will be of 2 minutes warm-up with intensity 20% of MIP. The training will be held with 3 sets of 15 repetitions, with 40% of MIP, finishing the training with 20% of MIP for 2 minutes. From the third week the protocol will be of 2 minutes warm-up with intensity 30% of MIP. The training will be held with 3 sets of 15 repetitions, with 60% of MIP, finishing the training with 30% of MIP for 2 minutes.
Exercise: see group Combined aerobic/resistance exercise
Low-intensity IMT + Aerobic/resistance exercise
Low-intensity IMT
Aerobic/resistance exercise
Sham IMT + Aerobic/resistance exercise
Aerobic session will consist of a 4-min of warm-up, 20 minutes of exercise, and 4 min of cool-down. Intensity will set by the formula: Training HR = (maximum HR - resting HR) × intensity % + resting HR. Patients will exercise using 30 seconds, high-intensity work phases 0.7% followed by 1-minute recovery bouts 0.5%. Resistance exercise will consist of dynamic lower and upper limb exercise. Upper limb exercises will include 3 sets of exercises for each muscle group performed with 10 repetitions each. Lower limb exercises will include 3 sets of exercises for each muscle group performed with 12 repetitions each. Resistance exercises will be performed at 12-MR.
Sham IMT + Aerobic/resistance exercise
Aerobic and resistance exercise
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High-intensity IMT + Aerobic/resistance exercise
High-intensity IMT
Low-intensity IMT + Aerobic/resistance exercise
Low-intensity IMT
Sham IMT + Aerobic/resistance exercise
Aerobic and resistance exercise
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* coronary revascularization;
* Decompensated heart failure functional class IV (NYHA);
* Recent transplant or hospitalization (6 months \<);
* Chronic Obstructive Pulmonary Disease;
* Neuromuscular, Orthopedic, Neurologic and Neoplastic Diseases;
* Recent myocardial infarction or cardiac surgery (less than 6 months);
* Atrial Fibrillation.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Bahia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mansueto Gomes Neto
Principal researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mansueto Gomes-Neto, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of Bahia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansueto Gomes Neto
Salvador, Estado de Bahia, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mansueto G Neto, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FUBahia HIIT IMT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.